Newsroom | 5037 results
Sorted by: Latest
-
Tandem Diabetes Care Announces Upcoming Conference Presentations
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: Citi’s 2026 Unplugged MedTech and Life Sciences Access Day on Thursday, February 26, 2026 at 1:45pm Eastern Time (10:45am Pacific Time), TD Cowen 46th Annual Health Care Conference on Wednesday, March 4, 2026 at 9:10am Eastern Time (6:10am Pacific Time), and Oppenhei...
-
Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results...
-
Vertex Reports Fourth Quarter and Full Year 2025 Financial Results
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2025, and provided its full year 2026 financial guidance. “2025 marked a year of strong revenue growth, commercial diversification, and pipeline advancement,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our focus in 2026 remains on executing across the CF franchise, bringing CASGEVY...
-
Vynleads (OTCQB: VYND) Launches Done With Diabetes™ App, Bringing AI-Powered Daily Lifestyle Support to Blood Sugar and Metabolic Health
ROCK HILL, S.C.--(BUSINESS WIRE)--Vynleads (OTCQB: VYND) Launches AI-Powered Done With Diabetes™ App for Daily Blood Sugar and Metabolic Health Support...
-
LifeScan Announces Transformational Partnership with i-SENS to Launch OneTouch® Continuous Glucose Monitoring System
MALVERN, Pa.--(BUSINESS WIRE)--LifeScan (“the “Company”), a world leader in glucose monitoring, today announced a transformational partnership with i-SENS, a global biosensor specialist, to launch a continuous glucose monitoring (“CGM”) system under the OneTouch® Vita brand. The Company and i-SENS expect to launch the CGM products in Germany, Ireland, Portugal, and Belgium by early 2027, with plans to expand into additional markets over time. This announcement reflects LifeScan’s long-term comm...
-
National Health Organizations Expand Proactive Care for Seniors With Cadence
NEW YORK--(BUSINESS WIRE)--Cadence today announced new partnerships with Corewell Health, Sharp Rees-Stealy Medical Group, Village Medical, and Yale New Haven Health – a diverse group of academic medical centers, integrated delivery networks, and physician-led organizations taking a more proactive approach to senior care to improve outcomes, ease clinician burden, and help patients stay healthier at home. For seniors in these programs, care continues beyond the doctor’s office. A dedicated Cade...
-
Eccogene Announces Positive Topline Results from Phase 1b Trial of Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist, in Adult Participants Living with Obesity/Overweight, with or without Type 2 Diabetes in China
SHANGHAI & BOSTON--(BUSINESS WIRE)--Eccogene Announces Positive Topline Results from Phase 1b Trial in China of Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist...
-
Vida Health Expands Cardiometabolic Care to Include MASH, Addressing a Fast-Growing Obesity-Related Cost Driver
SAN FRANCISCO--(BUSINESS WIRE)--Vida Health today announced the expansion of its clinical portfolio to include support for patients living with MASH....
-
CCS and SweetSpot Announce Strategic Partnership to Expand Access to Data-Driven Remote Care for People with Diabetes
ST. PETERSBURG, Fla.--(BUSINESS WIRE)--As diabetes continues to impact more than 40 million Americans, two leading healthcare companies are teaming up to bring care beyond the clinic. CCS, a leading provider of clinical solutions and home-delivered medical supplies for chronic conditions, and SweetSpot, an innovative remote diabetes management company, today announced a strategic partnership to address this gap. Together, CCS and SweetSpot are launching a new pilot program across select U.S. ma...
-
Trividia Health, Inc. Initiates Labeling Correction for all TRUE METRIX® Blood Glucose Monitoring Systems
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--Trividia Health, Inc., announced today that it is initiating a labeling correction which requires a modification of the Owner’s Booklets/System Instructions for Use for all TRUE METRIX, TRUE METRIX AIR, TRUE METRIX GO, and TRUE METRIX PRO Blood Glucose Monitoring Systems (collectively, the “Products”) distributed in the United States, United Kingdom, Mexico, Australia, and the Caribbean. Trividia is updating the E-5 Error Code in the “Messages” section of...